Published in Antimicrob Agents Chemother on September 01, 2003
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob Agents Chemother (2006) 1.46
Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. Antimicrob Agents Chemother (2008) 0.99
Investigational drugs for visceral leishmaniasis. Expert Opin Investig Drugs (2014) 0.79
Inhibition of hepatitis C virus replication by antimonial compounds. Antimicrob Agents Chemother (2005) 0.77
A potential link among antioxidant enzymes, histopathology and trace elements in canine visceral leishmaniasis. Int J Exp Pathol (2014) 0.76
Inhibition of Src homology 2 domain-containing phosphatase 1 increases insulin sensitivity in high-fat diet-induced insulin-resistant mice. FEBS Open Bio (2016) 0.75
Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate. Mem Inst Oswaldo Cruz (2014) 0.75
Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis (1997) 4.23
Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice. Clin Exp Immunol (1977) 3.19
Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis (1999) 2.92
Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis (1996) 2.72
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet (1992) 1.74
Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control Release (2000) 1.71
A study of the excretion of organic antimonials using a polarographic procedure. Biochem J (1943) 1.67
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc Trop Med Hyg (1988) 1.65
Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet (1980) 1.57
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol (1994) 1.42
The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. J Pharm Pharmacol (1988) 1.33
Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Trans R Soc Trop Med Hyg (1988) 1.17
The effect of a meal of meat on glomerular filtration rate in dogs at normal urine flows. J Physiol (1976) 1.17
Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta (1994) 1.10
The interaction of liposomes with the complement system. Crit Rev Ther Drug Carrier Syst (1998) 1.07
Toxicity of antimony and its compounds. Adverse Drug React Acute Poisoning Rev (1987) 1.04
Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B. Antimicrob Agents Chemother (1998) 0.97
Statistical analysis of pharmacokinetic data. J Vet Pharmacol Ther (1990) 0.94
Subacute toxicity of pentavalent antimony compounds in rats. Hum Exp Toxicol (1992) 0.94
Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations. Int J Immunopharmacol (1997) 0.92
Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconate. J Drug Target (1995) 0.92
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. Am J Vet Res (1984) 0.90
Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Vet Parasitol (1998) 0.89
Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation. Vet Parasitol (2001) 0.87
The distribution of free and non-ionic vesicular sodium stibogluconate in the dog. J Drug Target (1993) 0.86
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani. Antimicrob Agents Chemother (2001) 0.83
Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis. Res Vet Sci (1995) 0.83
Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs. Vet Rec (1996) 0.83
Applicability of anodic-stripping voltammetry and graphite furnace atomic-absorption spectrometry to the determination of antimony in biological matrices: a comparative study. Analyst (1985) 0.83
Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog. Res Vet Sci (1994) 0.82
Complement-mediated acute effects of liposome-encapsulated hemoglobin. Artif Cells Blood Substit Immobil Biotechnol (1999) 0.79
Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. Am J Trop Med Hyg (1997) 0.79
Mutation of a mutL homolog in hereditary colon cancer. Science (1994) 9.04
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol (1997) 4.08
Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell (1996) 3.81
A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA (2000) 3.06
The germ theory, beriberi, and the deficiency theory of disease. Med Hist (1977) 2.80
Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. Am J Trop Med Hyg (1999) 2.75
A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics (1997) 2.65
Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol (2003) 2.41
Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase. Proc Natl Acad Sci U S A (1997) 2.27
[Population reference values of the Spanish version of the Health Questionnaire SF-36]. Med Clin (Barc) (1998) 2.20
Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain. J Clin Microbiol (1999) 2.09
[Prevalence of obesity in Spain]. Med Clin (Barc) (1994) 2.02
A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg (2002) 1.97
Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans R Soc Trop Med Hyg (1995) 1.97
Leishmania in discarded syringes from intravenous drug users. Lancet (2002) 1.95
Prevalence of Leishmania infection among AIDS patients. Lancet (1992) 1.93
Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol Cell Biol (1997) 1.85
Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J Clin Microbiol (2001) 1.77
Leishmaniasis impact and treatment access. Clin Microbiol Infect (2011) 1.72
U2 and U1 snRNA gene loci associate with coiled bodies. J Cell Biochem (1995) 1.70
[Orbital lymphomas. Presentation of nine cases]. Arch Soc Esp Oftalmol (2008) 1.64
Koch's postulates in relation to the work of Jacob Henle and Edwin Klebs. Med Hist (1985) 1.61
Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem (2000) 1.59
Probing functional organization within the nucleus: is genome structure integrated with RNA metabolism? Cold Spring Harb Symp Quant Biol (1993) 1.56
Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant (2011) 1.54
Birth weight influences blood pressure values and variability in children and adolescents. Hypertension (2001) 1.54
Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B. Br J Dermatol (1998) 1.51
HIV co-infection with a currently non-pathogenic flagellate. Lancet (1996) 1.51
Genomic organization of the human PMS2 gene family. Genomics (1995) 1.50
Germ theory, hysteria, and Freud's early work in psychopathology. Med Hist (1980) 1.49
Ignaz Semmelweis, Carl Mayrhofer, and the rise of germ theory. Med Hist (1985) 1.47
[Detection of latent tuberculosis infection in peritoneal dialysis patients: new methods]. Nefrologia (2011) 1.47
[The main causes of death in Spain, 1992; comment]. Med Clin (Barc) (1996) 1.43
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol (1994) 1.42
Molecular cloning and functional analysis of a human cDNA encoding an Escherichia coli AlkB homolog, a protein involved in DNA alkylation damage repair. Nucleic Acids Res (1996) 1.41
Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol (1993) 1.41
[Resistance of Mycobacterium tuberculosis in the province of Castellón]. Arch Bronconeumol (1996) 1.40
SemmelWeis and his predecessors. Med Hist (1981) 1.40
[Migraine and MIDAS (MIDASELA) in Colombian hospital workers]. Rev Neurol (2003) 1.39
Magnetic and electric coherence in forward- and back-scattered electromagnetic waves by a single dielectric subwavelength sphere. Nat Commun (2012) 1.39
[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]. Med Clin (Barc) (1996) 1.38
Baseline entomological data for a pilot malaria control program in Equatorial Guinea. J Med Entomol (1993) 1.38
Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halos. J Cell Biol (1994) 1.37
Lower trypanosomatids in HIV/AIDS patients. Ann Trop Med Parasitol (2003) 1.36
A simple, rapid technique for precise mapping of multiple sequences in two colors using a single optical filter set. Genet Anal Tech Appl (1991) 1.34
The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. J Pharm Pharmacol (1988) 1.33
Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis. Eur J Immunol (2000) 1.32
Carbohydrate and energy-yielding metabolism in non-conventional yeasts. FEMS Microbiol Rev (2000) 1.31
VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J (1999) 1.29
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology (2001) 1.28
A PCR-based assay for the identification of the fish pathogen Renibacterium salmoninarum. FEMS Microbiol Lett (1994) 1.26
Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res (1997) 1.24
Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Vet J (2002) 1.24
Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. J Urol (2000) 1.22
Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood (1998) 1.21
Application and evaluation of QBC malaria diagnosis in a holoendemic area. Appl Parasitol (1994) 1.21
Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus. Am J Trop Med Hyg (1999) 1.21
Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect (2003) 1.20
Urine sample used for congenital toxoplasmosis diagnosis by PCR. J Clin Microbiol (1996) 1.19
Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis. Antimicrob Agents Chemother (1997) 1.18
Identification, chromosomal mapping and tissue-specific expression of hREV3 encoding a putative human DNA polymerase zeta. Carcinogenesis (1998) 1.17
Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med (2002) 1.15
One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care (2001) 1.15
The preparation and properties of niosomes--non-ionic surfactant vesicles. J Pharm Pharmacol (1985) 1.15
HIV and the transmission of Leishmania. Ann Trop Med Parasitol (2003) 1.14
Genome-wide association study for intramuscular fatty acid composition in an Iberian × Landrace cross. J Anim Sci (2012) 1.14
Localizing DNA and RNA within nuclei and chromosomes by fluorescence in situ hybridization. Genet Anal Tech Appl (1991) 1.14
Reed-Sternberg cell genome expression supports a B-cell lineage. Blood (1999) 1.14
The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg (1998) 1.13
The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis. Antimicrob Agents Chemother (2003) 1.13
Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol (1995) 1.12
Nephrotoxicity of combined cephalothin-gentamicin regimen. Arch Intern Med (1975) 1.12
Atlanto axial instability due to neurofibromatosis: case report. Acta Orthop Belg (2000) 1.12
Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS (1994) 1.09
Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery. Antimicrob Agents Chemother (1983) 1.09
Increased socioeconomic differences in mortality in eight Spanish provinces. Soc Sci Med (1995) 1.08
Time trend in incidence of HIV seroconversion among homosexual men repeatedly tested in Madrid, 1988--2000. AIDS (2001) 1.08
Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis. Blood (1999) 1.07
Fine mapping of porcine chromosome 6 QTL and LEPR effects on body composition in multiple generations of an Iberian by Landrace intercross. Genet Res (2005) 1.07
Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J (1996) 1.07
Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis. Vaccine (2007) 1.06
Comparative study of biosorption of heavy metals using different types of algae. Bioresour Technol (2007) 1.06
The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment. Eur J Immunol (1989) 1.05
Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol (2000) 1.05
T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol (1998) 1.05
Discrete amplifiable regions (amplicons) in the symbiotic plasmid of Rhizobium etli CFN42. J Bacteriol (1995) 1.05
The development of sex differences in the locus coeruleus of the rat. Brain Res Bull (2001) 1.04
Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J Parenter Enteral Nutr (1998) 1.04
Recruitment and development of the follicle; the roles of the transforming growth factor-beta superfamily. Mol Cell Endocrinol (2002) 1.04
Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice. J Pharm Pharmacol (1989) 1.03
Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome. Ann Intern Med (1988) 1.02
Rotavirus-associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J (2001) 1.01